人体血清胰岛素类生长因子-1的短期和中期预分析稳定性
Jaco C Louw1,2, Jaya A George1,2,3, Siyabonga P Khoza1,2
1Department of Chemical Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Clinical chemistry and laboratory medicine
|October 30, 2025
概括
胰岛素样生长因子-1 (IGF-1) 在采集后72小时内保持稳定,无论离心延迟或储存条件如何. 在4°C的冷藏将IGF-1的稳定性延长到7天.
科学领域:
- 生物化学 生物化学
- 内分泌学 在内分泌学.
- 临床诊断 临床诊断 临床诊断
背景情况:
- 胰岛素样生长因子-1 (IGF-1) 是一种重要的激素.
- 关于IGF-1的分析前稳定性的数据有限.
- 了解IGF-1稳定性对于准确的诊断测试至关重要.
研究的目的:
- 为了评估IGF-1的体外稳定性.
- 评估延迟离心对IGF-1稳定性的影响.
- 为了确定各种储存温度对IGF-1完整性的影响.
主要方法:
- 这项研究遵循了报告稳定性研究 (CRESS) 检查清单.
- 分析了来自10名健康成年人的血液样本.
- 样品经过立即或延迟离心 (8,24小时) 并在-20°C,4°C,20-25°C或30°C储存.
主要成果:
- IGF-1保持稳定至少72小时,无论离心延迟或储存温度如何.
- 在4°C的冷藏中保持稳定性长达168小时 (7天).
- 在-20°C冷,可保证其稳定性长达672小时 (28天).
结论:
- 在采样后72小时内,IGF-1表现出强大的稳定性.
- 建议在4°C冷藏,以将IGF-1的稳定性延长到7天.
- 这些发现支持临床实验室的灵活样本处理协议.
相关概念视频
Insulin Formulations: Types and Delivery
638
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
638
Insulin: Dosing Regimen and Adverse Effects
670
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
670
Insulin: Biosynthesis, Chemistry, and Preparation
1.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
172
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
172
Drug Product Stability
222
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
222


